Alembic Pharmaceuticals shareholders and shareholding pattern
NSE: APLLTDBSE: 533573Pharmaceuticals & BiotechnologySmall Cap
Last close ₹760.10down ₹21.20 (2.71%)BSE ₹758.75
Share price at the NSE close on 23 Oct 2026. Previous close ₹781.30.
52-week range of traded prices to 23 Oct 2026
₹635.80Low, 23 Mar 2026₹998.00High, 4 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹14,941 Cr430th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 4 Aug 2026
- 21.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 15 May 2026
- 2.6
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.58%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 4 Aug 2026
- 12.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 4 Aug 2026
- 11.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 15 May 2026
- 0.24
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,20,84752.2% delivered
Who owns Alembic Pharmaceuticals, filing by filing
Per cent of the company's shares. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters69.87%
- Foreign institutions4.55%
- Indian institutions15.43%
- GovernmentsNone
- Individuals and others10.15%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Foreign institutions
- Indian institutions
- Governments
- Individuals and others
| Per cent | Dec 2016Filed 13 Jan | Mar 2017Filed 7 Apr | Jun 2017Filed 7 Jul | Sep 2017Filed 7 Oct | Dec 2017Filed 13 Jan | Mar 2018Filed 11 Apr | Jun 2018Filed 17 Jul | Sep 2018Filed 11 Oct | Dec 2018Filed 8 Jan | Mar 2019Filed 16 Apr | Jun 2019Filed 19 Jul | Sep 2019Filed 9 Oct | Dec 2019Filed 8 Jan | Mar 2020Filed 10 Apr | Jun 2020Filed 7 Jul | Sep 2020Filed 7 Oct | Dec 2020Filed 7 Jan | Mar 2021Filed 7 Apr | Jun 2021Filed 7 Jul | Sep 2021Filed 6 Oct | Dec 2021Filed 7 Jan | Mar 2022Filed 7 Apr | Jun 2022Filed 7 Jul | Sep 2022Filed 11 Oct | Dec 2022Filed 18 Jan | Mar 2023Filed 7 Apr | Jun 2023Filed 7 Jul | Sep 2023Filed 10 Oct | Dec 2023Filed 10 Jan | Mar 2024Filed 10 Apr | Jun 2024Filed 10 Jul | Sep 2024Filed 10 Oct | Dec 2024Filed 20 Jan | Mar 2025Filed 18 Apr | Jun 2025Filed 16 Jul | Sep 2025Filed 14 Oct | Dec 2025Filed 9 Jan | Mar 2026Filed 10 Apr | Jun 2026Filed 15 Jul | Sep 2026Filed 16 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72.68% | 72.68% | 72.68% | 72.68% | 72.68% | 72.93% | 72.96% | 72.96% | 72.96% | 72.97% | 72.97% | 72.97% | 72.97% | 72.97% | 72.97% | 69.77% | 69.78% | 69.48% | 69.48% | 69.48% | 69.48% | 69.61% | 69.61% | 69.61% | 69.61% | 69.61% | 69.61% | 69.61% | 69.61% | 69.61% | 69.61% | 69.61% | 69.61% | 69.67% | 69.67% | 69.74% | 69.74% | 69.74% | 69.87% | 69.87% | |
| Indian promoters | 72.68% | 72.68% | 72.68% | 72.68% | 72.68% | 72.93% | 72.96% | 72.43% | 72.43% | 72.44% | 72.44% | 72.44% | 72.44% | 72.44% | 72.44% | 69.26% | 69.27% | 68.97% | 68.97% | 68.97% | 68.97% | 69.10% | 69.10% | 69.10% | 69.10% | 69.10% | 69.10% | 69.10% | 69.10% | 69.10% | 69.10% | 69.10% | 69.10% | 69.16% | 69.16% | 69.23% | 69.23% | 69.23% | 69.36% | 69.36% |
| Foreign promoters | – | – | – | – | – | – | – | 0.53% | 0.53% | 0.53% | 0.53% | 0.53% | 0.53% | 0.53% | 0.53% | 0.51% | 0.51% | 0.51% | 0.51% | 0.51% | 0.51% | 0.51% | 0.51% | 0.51% | 0.51% | 0.51% | 0.51% | 0.51% | 0.51% | 0.51% | 0.51% | 0.51% | 0.51% | 0.51% | 0.51% | 0.51% | 0.51% | 0.51% | 0.51% | 0.51% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 27.32% | 27.32% | 27.32% | 27.32% | 27.32% | 27.07% | 27.04% | 27.04% | 27.04% | 27.03% | 27.03% | 27.03% | 27.03% | 27.03% | 27.03% | 30.23% | 30.22% | 30.52% | 30.52% | 30.52% | 30.52% | 30.39% | 30.39% | 30.39% | 30.39% | 30.39% | 30.39% | 30.39% | 30.39% | 30.39% | 30.39% | 30.39% | 30.39% | 30.33% | 30.33% | 30.26% | 30.26% | 30.26% | 30.13% | 30.13% |
| Shares in issue | 18,85,15,914 | 18,85,15,914 | 18,85,15,914 | 18,85,15,914 | 18,85,15,914 | 18,85,15,914 | 18,85,15,914 | 18,85,15,914 | 18,85,15,914 | 18,85,15,914 | 18,85,15,914 | 18,85,15,914 | 18,85,15,914 | 18,85,15,914 | 18,85,15,914 | 19,65,63,124 | 19,65,63,124 | 19,65,63,124 | 19,65,63,124 | 19,65,63,124 | 19,65,63,124 | 19,65,63,124 | 19,65,63,124 | 19,65,63,124 | 19,65,63,124 | 19,65,63,124 | 19,65,63,124 | 19,65,63,124 | 19,65,63,124 | 19,65,63,124 | 19,65,63,124 | 19,65,63,124 | 19,65,63,124 | 19,65,63,124 | 19,65,63,124 | 19,65,63,124 | 19,65,63,124 | 19,65,63,124 | 19,65,63,124 | 19,65,63,124 |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Alembic Pharmaceuticals promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Nirayu Private Limited, 35.78%. The filing names 7 more members with no shares.Promoter buying and selling
| Holder | ||
|---|---|---|
| Nirayu Private LimitedIndian companies, trusts and others | 35.78% | 7,03,31,810 |
| Alembic LimitedIndian companies, trusts and others | 28.54% | 5,60,97,544 |
| Chirayu Ramanbhai AminIndividuals and Hindu undivided families | 2.13% | 41,92,529 |
| Malika Chirayu AminIndividuals and Hindu undivided families | 1.53% | 30,05,730 |
| Shaunak Chirayu AminIndividuals and Hindu undivided families | 0.51% | 10,06,980 |
| Pranav Chirayu AminIndividuals and Hindu undivided families | 0.51% | 10,09,800 |
| Udit Chirayu AminNon-resident and foreign individuals | 0.51% | 10,06,980 |
| Chirayu Ramanbhai Amin HUFIndividuals and Hindu undivided families | 0.11% | 2,18,295 |
| Gallup Trust (Pranav Chirayu Amin)Indian companies, trusts and others | 0.05% | 1,00,100 |
| Inaaya Shaunak AminIndividuals and Hindu undivided families | 0.04% | 80,000 |
| Naintara Shaunak AminIndividuals and Hindu undivided families | 0.04% | 80,000 |
| Barkha Pranav AminIndividuals and Hindu undivided families | 0.03% | 50,100 |
No promoter shares are reported as pledged.
Largest public holders of Alembic Pharmaceuticals, filing by filing
Per cent, on the same shares as the split above.Mutual funds holding Alembic Pharmaceuticals
| Holder | Dec 2016Filed 13 Jan | Mar 2017Filed 7 Apr | Jun 2017Filed 7 Jul | Sep 2017Filed 7 Oct | Dec 2017Filed 13 Jan | Mar 2018Filed 11 Apr | Jun 2018Filed 17 Jul | Sep 2018Filed 11 Oct | Dec 2018Filed 8 Jan | Mar 2019Filed 16 Apr | Jun 2019Filed 19 Jul | Sep 2019Filed 9 Oct | Dec 2019Filed 8 Jan | Mar 2020Filed 10 Apr | Jun 2020Filed 7 Jul | Sep 2020Filed 7 Oct | Dec 2020Filed 7 Jan | Mar 2021Filed 7 Apr | Jun 2021Filed 7 Jul | Sep 2021Filed 6 Oct | Dec 2021Filed 7 Jan | Mar 2022Filed 7 Apr | Jun 2022Filed 7 Jul | Sep 2022Filed 11 Oct | Dec 2022Filed 18 Jan | Mar 2023Filed 7 Apr | Jun 2023Filed 7 Jul | Sep 2023Filed 10 Oct | Dec 2023Filed 10 Jan | Mar 2024Filed 10 Apr | Jun 2024Filed 10 Jul | Sep 2024Filed 10 Oct | Dec 2024Filed 20 Jan | Mar 2025Filed 18 Apr | Jun 2025Filed 16 Jul | Sep 2025Filed 14 Oct | Dec 2025Filed 9 Jan | Mar 2026Filed 10 Apr | Jun 2026Filed 15 Jul | Sep 2026Filed 16 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Life Insurance Corporation of IndiaInsurance companies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.01% | 3.04% | 3.46% | 3.54% | 3.54% | 3.54% | 4.20% | 4.33% | 4.33% | 4.33% | 4.33% | 4.33% | 4.33% | 4.33% | 4.33% | 4.33% | 4.32% | 4.32% | 4.32% | 4.32% | 4.32% | 4.32% | 4.32% | 4.32% |
| Tata Aia Life Insurance Co Ltd Unit Linked Multi Cap FundInsurance companies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.01% | 1.15% | 1.57% | 1.86% | 1.81% | 1.15% | – |
| Nomura Singapore Limited ODIForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.08% | 1.08% | 1.09% | 1.09% | 1.11% | 1.11% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| HDFC Life Insurance Company LimitedInsurance companies | – | – | – | – | – | – | – | – | – | – | – | 1.03% | 1.36% | 1.60% | 1.36% | 2.20% | 2.13% | 2.25% | 2.15% | 2.08% | 1.76% | 1.59% | 1.41% | 1.30% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Elara India Opportunities Fund LimitedInstitutions Foreign Portfolio Investor | 1.41% | 1.39% | 1.36% | 1.35% | 1.36% | 1.26% | 1.23% | 1.23% | 1.24% | 1.23% | 1.24% | 1.24% | 1.38% | 1.11% | 1.03% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Matthews India FundInstitutions Foreign Portfolio Investor | 1.40% | 1.40% | 1.40% | 1.48% | 1.86% | 2.06% | 2.20% | 2.20% | 2.20% | 2.20% | 2.20% | 2.20% | 1.66% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Cresta Fund LimitedInstitutions Foreign Portfolio Investor | – | – | – | – | 1.35% | 1.35% | 1.35% | 1.35% | 1.35% | 1.34% | 1.36% | 1.36% | 1.06% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. Mutual funds are left out here: each fund's holding is on the Mutual funds tab, from its own portfolio. A dash is a filing that did not name the holder, which includes holding under one per cent.